Harbin Medical University Pharmaceutical Co Ltd.

To evaluate the safety and effectiveness of Ge Lanxiang oral liquid in the treatment of common cold (exogenous wind-heat with internal stagnation syndrome) under the conditions of widespread clinical use, and to investigate the efficacy of this product as a Mongolian medicine in the treatment of common cold.

Primary purpose: To evaluate the tolerance and safety of single and multiple administrations of the drug in patients with advanced solid tumors, and to determine its maximum tolerated dose and dose-limiting toxicity. Secondary purpose: To preliminarily evaluate the pharmacokinetic characteristics and efficacy of the drug in patients with advanced solid tumors. Exploratory purpose: To preliminarily explore the effects of the immunogenicity of the drug in the human body and the production of anti-drug antibodies on PK/PD, efficacy and safety; to preliminarily explore the effects of the drug on cytokines EGF/VEGF.